Jan 28, 20221 min readEVX Ventures | 2021 Year In Review We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:2021 YEAR IN REVIEW_EVX NEWSLETTER_A4_012822 v5 compressed.pdfDownload PDF • 1.32MB
We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:2021 YEAR IN REVIEW_EVX NEWSLETTER_A4_012822 v5 compressed.pdfDownload PDF • 1.32MB
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory BoardSINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey...
Carmine Therapeutics Announces First Close of Series A to Develop Non-viral Gene TherapyCambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...
Cargene Biopharma Welcomes Kathy He as CEOCargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI...
Comments